Continued Strong Revenue Growth Translated Into Significant Profit Growth Q4 2019 Financial Performance vs. Q4 2018 Business Highlights MACI full-year revenue growth of 35%, Epicel full- Vericel Q4 2019 Financial Results – February 25, 2020 3 +26% +66 bps +$5.1 million Total Revenue Growth Gross Margin Expansion Adjusted EBITDA Improvement VERICEL Q4 2019 RESULTS FEBRUARY 25, 2020 Safe Harbor This presentation contains forward-looking statements, including, without limitation, statements regarding full-year ...

VERICEL Q4 2020 RESULTS FEBRUARY 24, 2021 Safe Harbor 2 | --- | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------- ...

VERICEL Q4 2021 RESULTS FEBRUARY 24, 2022 Safe Harbor | --- | --- | --- ...

GRAND BAIE, MAURITIUS, July 03, 2025 (GLOBE NEWSWIRE) -- Alphamin Resources Corp. (AFM:TSXV, APH:JSE AltX)( “Alphamin” or the “Company”) is pleased to provide an operational update as follows: Q2 2025 contained tin production of 4,106 tonnes following a phased operational restart on 15 April 2025 (Q1 2025: 4,270 tonnes)Contained tin sales of 4,587 tonnes for the quarter, up 19% from the prior periodQ2 2025 EBITDA2,3 guidance of US$75m (Q1 2025 actual: US$62m)Strong cash flow generation with Net Cash increas ...

深圳市卫光生物制品股份有限公司 投资者关系活动记录表 编号：2025-002 证券代码：002880 证券简称：卫光生物 | | 特定对象调研 ☐分析师会议 | | --- | --- | | | ☐媒体采访 ☐业绩说明会 | | 投资者关系活动类 | ☐新闻发布会 ☐路演活动 | | 别 | ☐现场参观 | | | ☐其他 | | | 中信证券 王凯旋、亿能投资 衣景麟 | | 活动参与人员 | 公司董事会秘书、营销总监 金建军 | | | 公司董事会办公室主任 辛广斌 | | 时间 | 2025年7月3日 10:00-12:00 | | 地点 | 公司综合楼3楼会议室 | | 形式 | 现场调研 | | | 1.公司如何确保浆源稳定以及对于质量的把控？平果浆站是 | | | 否具备一定可复制性？ | | 交流内容及具体 | 答：公司实施增量培育和存量挖潜的浆源开拓策略，每年根据 | | | 上年度采浆情况并结合公司发展战略制定当年的采浆目标。近年 | | 问答记录 | 来，公司采浆规模实现了持续较好增长。公司目前已建立了完善的 | | | 血浆质量管理体系，并大力推进数字化监管体系建设和质量管理系 | ...

Financial Data and Key Metrics Changes - For fiscal year 2025, the company reported total revenue of $70.2 million, a slight decline from $72.5 million in fiscal year 2024, primarily due to the exit from the Middle East business [12] - Core adjusted EBITDA reached $7.4 million, an increase of 365% from $1.6 million in the previous year, exceeding guidance of $6 million to $7 million [4][15] - The company ended the year with $2.8 million in cash and $1.1 million in long-term debt, providing flexibility for ongoing initiatives [15] Business Line Data and Key Metrics Changes - North America revenue grew 15% year over year from $57 million to $65.5 million, highlighting strong momentum in core markets [7][12] - The company has shifted focus to private equity-backed companies and exited lower-value, non-core geographies, which has strengthened its business model [5][6] Market Data and Key Metrics Changes - North America now represents over 93.3% of the company's revenue base, indicating a significant concentration in this market [6] - The company is seeing increased adoption of large-scale digital transformation initiatives among clients, reflecting a growing demand for its services [6][17] Company Strategy and Development Direction - The company has made intentional decisions to sharpen its strategy by focusing on core business areas and exiting non-core markets [5] - A new AI-centered global capability center framework has been launched, integrating intelligent automation and data-driven decision systems [10][11] - The company plans to continue hiring key personnel with relationships in the private equity industry to expand its pipeline and network [6][17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in fiscal year 2026, projecting revenue between $74 million and $80 million and adjusted EBITDA between $6 million and $8 million [16][17] - The company is experiencing strong traction with clients, with existing clients deepening their partnerships and an expanding private equity network [17][18] Other Important Information - The restructuring process is complete, and stock-based compensation is expected to be significantly lower moving forward [13][15] - Fiscal year 2025 will be the last year to report core adjusted EBITDA as a separate metric, transitioning to adjusted EBITDA and GAAP measures [15] Q&A Session Summary - No specific questions or answers were provided in the content regarding the Q&A session.

Financial Data and Key Metrics Changes - For fiscal year 2025, the company reported total revenue of $70.2 million, a decrease from $72.5 million in fiscal year 2024, primarily due to the exit from the Middle East business [11] - Core adjusted EBITDA reached $7.4 million, an increase of 365% from $1.6 million in the previous year, exceeding guidance [14] - The company ended the year with $2.8 million in cash and $1.1 million in long-term debt, providing flexibility for ongoing initiatives [14] Business Line Data and Key Metrics Changes - North America revenue grew 15% year over year from $57 million to $65.5 million, highlighting strong momentum in core markets [11][7] - The company has shifted focus to private equity-backed companies, enhancing its global capability center (GCC) model, which is now a preferred method for scalable capabilities in technology and operations [6][7] Market Data and Key Metrics Changes - North America now represents over 93.3% of the company's revenue base, indicating a significant concentration in this market [6] - The company is experiencing high client retention and increased adoption of large-scale digital transformation initiatives [6] Company Strategy and Development Direction - The company has exited lower-value, non-core geographies, specifically the Middle East consulting market, and has completed associated write-offs [5] - A new AI-centered GCC framework has been launched, integrating intelligent automation and data-driven decision systems to enhance client capabilities [9][10] - The company plans to continue hiring key personnel with relationships in the private equity industry to expand its pipeline and network [6] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in fiscal year 2026, projecting revenue between $74 million and $80 million and adjusted EBITDA between $6 million and $8 million [15][16] - The company is seeing strong traction with clients, with existing clients deepening partnerships and an expanding private equity network [16] - The cost structure is now lean, and AI-led transformation is gaining pace, indicating a positive outlook for future performance [17] Other Important Information - The restructuring process is complete, and stock-based compensation is expected to be significantly lower moving forward [12] - Fiscal year 2025 will be the last year to report core adjusted EBITDA as a separate metric, transitioning to adjusted EBITDA and GAAP measures [14] Q&A Session Summary - No specific questions or answers were provided in the content, indicating that the call concluded without a Q&A segment [19]

ZENVIA New Strategic Cycle 1Q 2025 Earnings Presentation Key Key Key Shay Chor Financial CFO Highlights Q1: Strong top-line growth and G&A efficiencies did not offset margin pressure 43 43 56.4% 53.7% 30.0% 40.0% 50.0% 60.0% 70.0% 80.0% 0.0 20.0 40.0 Q1 2024 Q1 2025 23 31 17% 14% 0 0% 10 20 30 Q1 2024 Q1 2025 24 20 0 20 40 Q1 2024 Q1 2025 94 74 44.0% 25.1% 10.0% 30.0% 50.0% 70.0% 0.0 50.0 100.0 Q1 2024 Q1 2025 213 296 Q1 2024 Q1 2025 Net Revenues (BRL MM) G&A Expenses and G&A-to-Revenues (BRL MM & %) EBITDA ...

Jefferies Global Life Sciences Conference Ingmar Bruns, M.D., CMO June 2025 Nasdaq: ZNTL Forward Looking Statements and Disclaimer Zentalis Pharmaceuticals, Inc. ("we," "us," "our," "Zentalis" or the "Company") cautions that this presentation (including oral commentary that accompanies this presentation) contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do not relate to matters of historical ...

严牌股份紧扣新时代绿色中国发展战略，立足既有技术与市场优势，加大研发创新、扩容产能规模，稳 步推进高质量发展。2024年公司实现营收7.85亿元，同比增长8.75%，2025年一季度实现营收2.00亿 元，同比增长16.49%，增长势头持续显现。公司目前拥有多条进口针刺无纺布生产线及两百多台织 机，具备数千万平方米级针刺无纺滤布和机织滤布产能，生产规模业内领先，可快速组织生产与交付； 同时通过设立子公司从事原材料研产销，形成产业协同效应，保障供应链稳定与质量可控，有效降低成 本。 2025年1月，严牌股份首发募投的高性能过滤材料生产基地、高性能过滤带生产基地项目已结项，初步 缓解公司产能压力。2024年，公司向不特定对象发行可转债募集资金4.68亿元，用于高性能过滤材料智 能化产业项目及补充流动资金。高性能过滤材料智能化产业项目总投资4.73亿元，项目建设完成后，严 牌股份将新增年产919万平方米高性能过滤材料的生产能力，不仅将进一步扩大高性能产品产能、丰富 主营业务品类以强化环保过滤领域核心竞争力，还将通过引入自动化、智能化设备推动生产与管理升 级，助力效率提升与业务持续高效发展。 严牌股份在深耕国内市场的 ...